mRNA-0184

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for mRNA-0184, covering 2025-03-17 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants [Phase 1]

See pricing